2.3.1.255 Breast Neoplasms https://pubmed.ncbi.nlm.nih.gov/10464641/ Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer. causal interaction 3 2.3.1.255 Breast Neoplasms https://pubmed.ncbi.nlm.nih.gov/10464641/ Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer. diagnostic usage 3 2.3.1.255 Breast Neoplasms https://pubmed.ncbi.nlm.nih.gov/10464641/ Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer. therapeutic application 3 2.3.1.255 Breast Neoplasms https://pubmed.ncbi.nlm.nih.gov/10464641/ Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer. unassigned - 2.3.1.255 Carcinogenesis https://pubmed.ncbi.nlm.nih.gov/18794801/ Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. causal interaction 2 2.3.1.255 Carcinogenesis https://pubmed.ncbi.nlm.nih.gov/18794801/ Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. ongoing research 2 2.3.1.255 Carcinogenesis https://pubmed.ncbi.nlm.nih.gov/18794801/ Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. unassigned - 2.3.1.255 Neoplasms https://pubmed.ncbi.nlm.nih.gov/19716809/ Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation. ongoing research 4 2.3.1.255 Neoplasms https://pubmed.ncbi.nlm.nih.gov/19716809/ Phosphorylation of ARD1 by IKKbeta contributes to its destabilization and degradation. unassigned - 2.3.1.255 Thyroid Neoplasms https://pubmed.ncbi.nlm.nih.gov/20178098/ Depletion of the human N(alpha)-terminal acetyltransferase A (hNatA) induces p53-dependent apoptosis and p53-independent growth inhibition. therapeutic application 1